Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 433

1.

Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.

Ríos M, Delgado E, Pérez-Alvarez L, Fernández J, Gálvez P, de Parga EV, Yung V, Thomson MM, Nájera R.

J Med Virol. 2007 Jun;79(6):647-56.

PMID:
17457921
2.

HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.

Cardoso LP, Pereira GA, Viegas AA, Schmaltz LE, Stefani MM.

J Med Virol. 2010 Mar;82(3):351-7. doi: 10.1002/jmv.21722.

PMID:
20087934
3.

HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.

Aulicino PC, Rocco CA, Mecikovsky D, Bologna R, Mangano A, Sen L.

Antivir Ther. 2010;15(4):641-50. doi: 10.3851/IMP1571.

PMID:
20587857
4.

Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.

Handema R, Terunuma H, Kasolo F, Kasai H, Sichone M, Yamashita A, Deng X, Mulundu G, Ichiyama K, Munkanta M, Yokota T, Wakasugi N, Tezuka F, Yamamoto N, Ito M.

AIDS Res Hum Retroviruses. 2003 Feb;19(2):151-60.

PMID:
12643279
5.

High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.

Pérez-Alvarez L, Carmona R, Muñoz M, Delgado E, Thomson MM, Contreras G, Pedreira JD, Rodríguez Real R, Vázquez de Parga E, Medrano L, Taboada JA, Nájera R; Spanish Group for Antiretroviral Resistance Studies in Galicia.

Antivir Ther. 2003 Aug;8(4):355-60.

PMID:
14518705
6.

Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union.

Vázquez de Parga E, Rakhmanova A, Pérez-Alvarez L, Vinogradova A, Delgado E, Thomson MM, Casado G, Sierra M, Muñoz M, Carmona R, Vega Y, Contreras G, Medrano L, Osmanov S, Nájera R.

J Med Virol. 2005 Nov;77(3):337-44.

PMID:
16173024
7.

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.

Bellocchi MC, Forbici F, Palombi L, Gori C, Coelho E, Svicher V, D'Arrigo R, Emberti-Gialloreti L, Ceffa S, Erba F, Marazzi MC, Silberstein FC, Perno CF.

J Med Virol. 2005 Aug;76(4):452-8.

PMID:
15977236
8.

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.

Couto-Fernandez JC, Silva-de-Jesus C, Veloso VG, Rachid M, Gracie RS, Chequer-Fernandez SL, Oliveira SM, Arakaki-Sanchez D, Chequer PJ, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):73-8. Epub 2005 Apr 12.

9.

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.

Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.

J Med Virol. 2004 Jul;73(3):350-61.

PMID:
15170628
10.

Lack of high-level resistance mutations in HIV type 1 BF recombinant strains circulating in northeast Brazil.

Monteiro-Cunha JP, Araujo AF, Santos E, Galvao-Castro B, Alcantara LC.

AIDS Res Hum Retroviruses. 2011 Jun;27(6):623-31. doi: 10.1089/AID.2010.0126. Epub 2011 Jan 15.

PMID:
21087197
12.

High prevalence of unique recombinant forms of HIV-1 in Ghana: molecular epidemiology from an antiretroviral resistance study.

Delgado E, Ampofo WK, Sierra M, Torpey K, Pérez-Alvarez L, Bonney EY, Mukadi YD, Lartey M, Nyarko C, Amenyah RN, Thomson M, Nájera R.

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):599-606. doi: 10.1097/QAI.0b013e3181806c0e.

PMID:
18645511
13.

Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.

Ferreira AS, Cardoso LP, Stefani MM.

J Med Virol. 2011 Aug;83(8):1301-7. doi: 10.1002/jmv.22128.

PMID:
21678433
14.

Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study.

Delgado E, León-Ponte M, Villahermosa ML, Cuevas MT, Deibis L, Echeverría G, Thomson MM, Pérez-Alvarez L, Osmanov S, Nájera R.

AIDS Res Hum Retroviruses. 2001 May 20;17(8):753-8.

PMID:
11429115
15.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

16.

Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.

Derache A, Traore O, Koita V, Sylla A, Tubiana R, Simon A, Canestri A, Carcelain G, Katlama C, Calvez V, Cisse M, Marcelin AG.

Antivir Ther. 2007;12(1):123-9.

PMID:
17503757
17.

Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.

Kandathil AJ, Kannangai R, Verghese VP, Pulimood SA, Rupali P, Sridharan G, Grant P, Pillay D, Abraham OC.

Indian J Med Microbiol. 2009 Jul-Sep;27(3):231-6. doi: 10.4103/0255-0857.53205.

18.

Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia.

Tee KK, Kamarulzaman A, Ng KP.

Med Microbiol Immunol. 2006 Jun;195(2):107-12. Epub 2006 Jan 11.

PMID:
16404607
19.

HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.

Cardoso LP, Queiroz BB, Stefani MM.

J Clin Virol. 2009 Oct;46(2):134-9. doi: 10.1016/j.jcv.2009.07.009. Epub 2009 Aug 13.

PMID:
19682948
20.

Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia.

Avi R, Huik K, Sadam M, Karki T, Krispin T, Ainsalu K, Paap P, Schmidt J, Nikitina N, Lutsar I.

J Med Virol. 2009 Jun;81(6):953-8. doi: 10.1002/jmv.21482.

PMID:
19382254
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk